These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1557786

  • 1. In vivo and in vitro toxicity of phospholipase C from Pseudomonas aeruginosa.
    Meyers DJ, Palmer KC, Bale LA, Kernacki K, Preston M, Brown T, Berk RS.
    Toxicon; 1992 Feb; 30(2):161-9. PubMed ID: 1557786
    [Abstract] [Full Text] [Related]

  • 2. Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.
    Meyers DJ, Berk RS.
    Infect Immun; 1990 Mar; 58(3):659-66. PubMed ID: 2106492
    [Abstract] [Full Text] [Related]

  • 3. Role of hemolytic and nonhemolytic phospholipase C from Pseudomonas aeruginosa for inflammatory mediator release from human granulocytes.
    König B, Vasil ML, König W.
    Int Arch Allergy Immunol; 1997 Feb; 112(2):115-24. PubMed ID: 9030090
    [Abstract] [Full Text] [Related]

  • 4. A simple and reliable method for rapid production and purification of Pseudomonas aeruginosa haemolytic phospholipase C.
    Dubouix A, Nieto M, Fauvel J, Chap H, Marty N, Salles JP, Gaits F.
    Lett Appl Microbiol; 2004 Feb; 38(3):191-6. PubMed ID: 14962039
    [Abstract] [Full Text] [Related]

  • 5. Identification of a new phospholipase C activity by analysis of an insertional mutation in the hemolytic phospholipase C structural gene of Pseudomonas aeruginosa.
    Ostroff RM, Vasil ML.
    J Bacteriol; 1987 Oct; 169(10):4597-601. PubMed ID: 2820937
    [Abstract] [Full Text] [Related]

  • 6. Role of haemolytic and non-haemolytic phospholipase C from Pseudomonas aeruginosa in interleukin-8 release from human monocytes.
    König B, Vasil ML, König W.
    J Med Microbiol; 1997 Jun; 46(6):471-8. PubMed ID: 9350199
    [Abstract] [Full Text] [Related]

  • 7. Pathomorphological characteristics of experimental toxemia induced by thermostable Yersinia pseudotuberculosis toxin.
    Isachkova LM, Timchenko NF, Nedashkovskaya EP, Raznik SD.
    Bull Exp Biol Med; 2000 Nov; 130(11):1123-6. PubMed ID: 11182834
    [Abstract] [Full Text] [Related]

  • 8. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK, Melville SB.
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [Abstract] [Full Text] [Related]

  • 9. Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa.
    Coutinho IR, Berk RS, Mammen E.
    Thromb Res; 1988 Sep 01; 51(5):495-505. PubMed ID: 3140410
    [Abstract] [Full Text] [Related]

  • 10. Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa.
    Berka RM, Gray GL, Vasil ML.
    Infect Immun; 1981 Dec 01; 34(3):1071-4. PubMed ID: 6800952
    [Abstract] [Full Text] [Related]

  • 11. In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.
    Berk RS, Brown D, Coutinho I, Meyers D.
    Infect Immun; 1987 Jul 01; 55(7):1728-30. PubMed ID: 3110070
    [Abstract] [Full Text] [Related]

  • 12. [Liver, lung, kidney, heart and spleen structure of rats after multiple intravenous injections of magnetite nanosuspension].
    Mil'go IV, Sukhodolo IV.
    Vestn Ross Akad Med Nauk; 2012 Jul 01; (3):75-9. PubMed ID: 22712279
    [Abstract] [Full Text] [Related]

  • 13. [Morphological changes in the internal organs caused by the lecithinase-C of Cl. welchii, type A].
    Anosov IIa, Ispolatovskaia MV, Larina IA.
    Arkh Patol; 1966 Jul 01; 28(10):42-7. PubMed ID: 4304507
    [No Abstract] [Full Text] [Related]

  • 14. [Histopathological changes produced in organs by platelet activating factor].
    Takiguchi T, Luo XX, Ogata H, Ishitobi F, Iidaka K.
    Masui; 1994 Aug 01; 43(8):1161-6. PubMed ID: 7933496
    [Abstract] [Full Text] [Related]

  • 15. [Expression of the phospholipase C gene of Pseudomonas aeruginosa in Escherichia coli and Pseudomonas].
    Zinov'eva VN, Sever IS, Vakhrameeva GM.
    Mol Gen Mikrobiol Virusol; 1989 Sep 01; (9):33-8. PubMed ID: 2515430
    [Abstract] [Full Text] [Related]

  • 16. [Histological study of dog organs under the effect of sibiromycin].
    Muraveĭskaia VS.
    Antibiotiki; 1971 Sep 01; 16(9):810-6. PubMed ID: 5139453
    [No Abstract] [Full Text] [Related]

  • 17. Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa.
    Shortridge VD, Lazdunski A, Vasil ML.
    Mol Microbiol; 1992 Apr 01; 6(7):863-71. PubMed ID: 1602966
    [Abstract] [Full Text] [Related]

  • 18. Experimental infections with protease-deficient mutants of Pseudomonas aeruginosa in mice.
    Wretlind B, Kronevi T.
    J Med Microbiol; 1978 May 01; 11(2):145-54. PubMed ID: 96256
    [Abstract] [Full Text] [Related]

  • 19. Histological alterations in mice induced by Pseudomonas aeruginosa slime glycolipoprotein.
    Papadaki HI, Dimitracopoulos G, Bonicos D, Petrou G, Anastassiou ED.
    J Exp Pathol; 1990 May 01; 5(1):7-18. PubMed ID: 2118950
    [Abstract] [Full Text] [Related]

  • 20. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D, Majtán V.
    Pharmazie; 1997 Feb 01; 52(2):157-9. PubMed ID: 9122276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.